Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-19-2926
Abstract: Through metabolic subtyping, metabolic vulnerabilities can be exploited for developing efficacious treatments. A glycolytic subtype indicates poor survival in patients with pancreatic cancer, whereas a cholesterogenic subtype correlates with better outcomes potentially due to more…
read more here.
Keywords:
metabolic subtyping;
novel personalized;
cancer;
personalized therapies ... See more keywords